Microbot Medical Inc. – NASDAQ:MBOT

Add to watchlist

$3.17

+2.05

+185.54%

Market closed

Open in about 8 hours

+2.78%

month

+2.78%

quarter

-15.91%

year

Market Cap	16.42M
Enterprise value	11.30M

P/E	-1.04
EV/Sales	N/A
EV/EBITDA	-1.72
Price/Sales	N/A
Price/Book	1.82
PEG ratio	N/A
EPS	-0.9

Revenue	N/A
EBITDA	-9.21M
Income	-10.25M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Microbot Medical Inc. (NASDAQ:MBOT): Profit margin
Jun 2023	0	-2.28M
Sep 2023	0	-2.44M
Dec 2023	142K	-3.15M	-2221.13%
Mar 2024	0	-2.37M

Microbot Medical Financials Estimate

Q Y

Microbot Medical Inc. (NASDAQ:MBOT): Analyst Estimates
Dec 2023	142K	-3.15M	-2221.13%
Mar 2024	0	-2.37M
Oct 2025	0	-1.82M
Dec 2025	0	-1.82M

Analysts Price target
Financials & Ratios estimates

Microbot Medical Inc. (NASDAQ:MBOT): Earnings per share (EPS)
2022-11-14	-0.47079	-0.49
2023-03-29	-0.47	-0.54

Microbot Medical Inc. (NASDAQ:MBOT): Debt to assets
Jun 2023	10884000	1.41M	13.01%
Sep 2023	8888000	1.53M	17.21%
Dec 2023	8327000	3.82M	45.95%
Mar 2024	7367000	1.2M	16.29%

Microbot Medical Inc. (NASDAQ:MBOT): Cash Flow
Jun 2023	-1.85M	-1.29M	6.71M
Sep 2023	-1.65M	-2.57M	-161K
Dec 2023	-1.82M	2.95M	-6.55M
Mar 2024	-2.42M	-1.28M	2.39M

Microbot Medical alternative data

Microbot Medical Inc. (NASDAQ:MBOT): Employee count
Aug 2023	18
Sep 2023	18
Oct 2023	18
Nov 2023	18
Dec 2023	18
Jan 2024	18
Feb 2024	18
Mar 2024	18
Apr 2024	21
May 2024	21
Jun 2024	21
Jul 2024	21

Microbot Medical
Hedge Funds Holdings Q1 2023

5.19% -15.76%

of MBOT is owned by hedge funds

14 -7

hedge funds hold MBOT stock

368.97K -1.11M

shares is hold by hedge funds

MBOT hedge funds holdings changes

Microbot Medical
Insider Trading

Microbot Medical Inc. (NASDAQ:MBOT): Insider trades (number of shares)
Period	Buy	Sel
Dec 2019	0	40000
Aug 2020	0	30238
Oct 2020	0	104881

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Sale	19 Oct 2020	BORNSTEIN YOSEPH director	Common Stock	4,881	N/A	N/A
Sale	12 Oct 2020	BORNSTEIN YOSEPH director	Common Stock	20,000	$7.85	$156,900
Sale	5 Oct 2020	BORNSTEIN YOSEPH director	Common Stock	40,000	$7.78	$311,080
Sale	5 Oct 2020	BORNSTEIN YOSEPH director	Common Stock	40,000	$2.58	$103,240
Sale	17 Aug 2020	BORNSTEIN YOSEPH director	Common Stock	15,119	$11.05	$166,989
Sale	17 Aug 2020	BORNSTEIN YOSEPH director	Common Stock	15,119	$5.09	$76,941
Sale	23 Dec 2019	GADOT HAREL director, officer..	Common Stock, par value $0.01 per share	40,000	$10	$400,000
Purchase	14 Jan 2019	MONA JOSEPH 10 percent owner 10 percent owner	Microbot Medical Common Stock	1,773	N/A	N/A
Sale	14 Jan 2019	MONA JOSEPH 10 percent owner 10 percent owner	Microbot Medical Common Stock	281,773	N/A	N/A
Purchase	9 Jan 2019	MONA JOSEPH 10 percent owner 10 percent owner	Microbot Medical Common Stock	14,280	$2.19	$31,273

MBOT insider trading transactions

Microbot Medical
Earnings Call Transcripts

Quarter	Transcript
Q2 2017 14 Aug 2017	Q2 2017 Earnings Call Transcript
Q4 2015 24 Mar 2016	Q4 2015 Earnings Call Transcript
Q2 2015 8 Aug 2015	Q2 2015 Earnings Call Transcript
Q1 2015 5 May 2015	Q1 2015 Earnings Call Transcript

MBOT earnings call transcripts

Microbot Medical
Executives

Insider	Age	Compensation
Mr. Harel Gadot (1973) Co-Founder, Pres, Chief Executive Officer & Chairman	52	$733,800
Dr. Eyal Morag M.D. (1965) Chief Medical Officer	60	$371,580
Mr. David Ben Naim CPA, M.B.A. (1969) Chief Financial Officer	56	$82,240
Mr. Yoseph Bornstein (1959) Co-Founder & Independent Director	66	$38,750

Microbot Medical
Latest News

Thursday, 12 December 2024
12:56	MBOT Stock Gains Following FDA Submission of the LIBERTY System	zacks.com
Tuesday, 10 December 2024
10:18	Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access	globenewswire.com
Wednesday, 16 October 2024
13:25	Microbot Medical Stock Rises After Completing ACCESS-PVI Trial	zacks.com
Tuesday, 15 October 2024
08:38	Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025	globenewswire.com
Monday, 30 September 2024
08:30	Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up	globenewswire.com
Tuesday, 17 September 2024
08:30	Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System	globenewswire.com
Friday, 23 August 2024
13:01	Microbot Medical (MBOT) Inks New Phase 2 Agreement for LIBERTY	zacks.com
Thursday, 22 August 2024
08:30	Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System	globenewswire.com
Monday, 19 August 2024
12:05	Microbot Medical (MBOT) Gets Quality Certification for its System	zacks.com
Tuesday, 13 August 2024
08:30	Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization	globenewswire.com
Monday, 5 August 2024
12:30	Microbot Medical (MBOT) Inks Deal to Test Autonomous Robotics	zacks.com
Thursday, 1 August 2024
08:30	Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System	globenewswire.com
Thursday, 18 July 2024
08:30	Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center	globenewswire.com
Thursday, 11 July 2024
14:51	Microbot Medical (MBOT) Progresses in Its Human Clinical Trial	zacks.com
Tuesday, 9 July 2024
08:30	Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial	globenewswire.com
Monday, 8 July 2024
08:20	Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial	globenewswire.com
Friday, 5 July 2024
12:51	Microbot Medical (MBOT) Inks Agreement to Begin LIBERTY Trial	zacks.com
Thursday, 4 July 2024
14:50	Microbot (MBOT) Inks a New Agreement to Begin Trial on LIBERTY	zacks.com
Wednesday, 3 July 2024
08:20	Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial	globenewswire.com
Thursday, 20 June 2024
08:25	Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial	globenewswire.com
Monday, 17 June 2024
08:30	Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial	globenewswire.com
Tuesday, 4 June 2024
16:20	Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules	globenewswire.com
Monday, 3 June 2024
12:11	Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules	globenewswire.com
08:20	Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial	globenewswire.com
Monday, 29 April 2024
08:30	Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™	globenewswire.com
Monday, 15 April 2024
08:30	Microbot Medical Shares Status Following Recent Geopolitical Events	globenewswire.com
Wednesday, 7 February 2024
11:11	Microbot Medical (MBOT) Files IDE to Start Human Clinical Study	Zacks Investment Research
Sunday, 10 December 2023
14:31	3 Stocks at the Forefront of Medical Robotics	InvestorPlace
Friday, 8 September 2023
10:02	Microbot Medical Gains Global Recognition; Professor Vincent Vidal to Present an Abstract on The LIBERTY® Robotic Surgical System at CIRSE 2023	GlobeNewsWire
Tuesday, 23 May 2023
14:25	3 Undervalued Penny Stocks to Buy for Multi-Bagger Returns	InvestorPlace

Frequently Asked Questions (FAQ)

What's the price of Microbot Medical stock today?

One share of Microbot Medical stock can currently be purchased for approximately $3.17.
When is Microbot Medical's next earnings date?

Unfortunately, Microbot Medical's (MBOT) next earnings date is currently unknown.
Does Microbot Medical pay dividends?

No, Microbot Medical does not pay dividends.
How much money does Microbot Medical make?

Microbot Medical has a market capitalization of 16.42M. Microbot Medical made a loss 10.74M US dollars in net income (profit) last year or -$0.54 on an earnings per share basis.
What is Microbot Medical's stock symbol?

Microbot Medical Inc. is traded on the NASDAQ under the ticker symbol "MBOT".
What is Microbot Medical's primary industry?

Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.
How do i buy shares of Microbot Medical?

Shares of Microbot Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are Microbot Medical's key executives?
Microbot Medical's management team includes the following people:
- Mr. Harel Gadot Co-Founder, Pres, Chief Executive Officer & Chairman(age: 52, pay: $733,800)
- Dr. Eyal Morag M.D. Chief Medical Officer(age: 60, pay: $371,580)
- Mr. David Ben Naim CPA, M.B.A. Chief Financial Officer(age: 56, pay: $82,240)
- Mr. Yoseph Bornstein Co-Founder & Independent Director(age: 66, pay: $38,750)
Is Microbot Medical founder-led company?

Yes, Microbot Medical is a company led by its founders Mr. Harel Gadot and Mr. Yoseph Bornstein.
How many employees does Microbot Medical have?

As Jul 2024, Microbot Medical employs 21 workers.
When Microbot Medical went public?

Microbot Medical Inc. is publicly traded company for more then 33 years since IPO on 25 Mar 1992.
What is Microbot Medical's official website?

The official website for Microbot Medical is microbotmedical.com.
Where are Microbot Medical's headquarters?

Microbot Medical is headquartered at 25 Recreation Park Drive, Hingham, MA.
How can i contact Microbot Medical?

Microbot Medical's mailing address is 25 Recreation Park Drive, Hingham, MA and company can be reached via phone at +7 818753605.

Microbot Medical Inc.

microbotmedical.com

Exchange:

NASDAQ

Full time employees:

Industry:

Medical - Instruments & Supplies

Sector:

Healthcare

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

+7 818753605

25 Recreation Park Drive
Hingham, MA 02043

CIK: 0000883975
ISIN: US59503A2042
CUSIP: 59503A204